Kidney Imaging Surveillance in Commercially Insured Patients With Tuberous Sclerosis Complex.
暂无分享,去创建一个
[1] R. Touraine,et al. Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] O. Rouvière,et al. Renal manifestations of tuberous sclerosis complex: patients’ and parents’ knowledge and routines for renal follow-up – a questionnaire study , 2018, BMC Nephrology.
[3] B. Korf,et al. Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas. , 2017, Urology.
[4] J. Bissler,et al. Long-term Clinical Morbidity in Patients With Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex. , 2016, Urology.
[5] P. Nasuti,et al. The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD) , 2016, Journal of medical economics.
[6] B. Korf,et al. Epilepsy treatment patterns among patients with tuberous sclerosis complex , 2016, Journal of the Neurological Sciences.
[7] P. Bolton,et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD). , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[8] M. Eijkemans,et al. Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] D. Krueger,et al. Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference , 2013, Pediatric neurology.
[10] M. Kohrman,et al. Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis , 2012, Current medical research and opinion.
[11] C. Martyn,et al. An epidemiological study of renal pathology in tuberous sclerosis complex , 2004, BJU international.
[12] J. Bissler,et al. Tuberous sclerosis complex: renal imaging findings. , 2002, Radiology.
[13] K. Takeda,et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. , 2002, Radiology.
[14] H. Northrup,et al. Tuberous Sclerosis Consensus Conference: Recommendations for Diagnostic Evaluation , 1999, Journal of child neurology.
[15] J. Osborne,et al. End-stage renal failure in adults with the tuberous sclerosis complex. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] T. Hensle,et al. The tuberous sclerosis complex: a comprehensive review. , 1998, Journal of the American College of Surgeons.
[17] M. Delgado,et al. Renal lesion growth in children with tuberous sclerosis complex. , 1998, The Journal of urology.
[18] M. Dickinson,et al. Renal angiomyolipoma: optimal treatment based on size and symptoms. , 1998, Clinical nephrology.
[19] J. Sampson,et al. A cross sectional study of renal involvement in tuberous sclerosis. , 1996, Journal of medical genetics.
[20] J. Osborne,et al. MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDY , 1996, Developmental medicine and child neurology.
[21] H. Neumann,et al. Tuberous sclerosis complex with end-stage renal failure. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] S. Verhoef,et al. The evolution of renal angiomyolipomas in patients with tuberous sclerosis. , 1994, The Journal of urology.
[23] C. Crowson,et al. Causes of death in patients with tuberous sclerosis. , 1991, Mayo Clinic proceedings.
[24] J. Osborne,et al. Epidemiology of Tuberous Sclerosis , 1991, Annals of the New York Academy of Sciences.
[25] E. Fishman,et al. The management of renal angiomyolipoma. , 1986, The Journal of urology.
[26] B. McCoy,et al. A Review of Investigations for Patients With Tuberous Sclerosis Complex Who Were Referred to the Tuberous Sclerosis Clinic at The Hospital for Sick Children: Identifying Gaps in Surveillance. , 2019, Pediatric neurology.
[27] J. Bissler,et al. Renal angiomyolipomata. , 2004, Kidney international.
[28] D. Kwiatkowski,et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. , 2001, American journal of human genetics.